Belimumab was recently approved for treatment of lupus glomerulonephritis (LN).

Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort

Saccon, Francesca;Larosa, Maddalena;Orsolini, Giovanni;Rossini, Maurizio;
2021-01-01

Abstract

Belimumab was recently approved for treatment of lupus glomerulonephritis (LN).
Belimumab
Lupus nephritis
Renal response
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1050066
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact